/Companies

BBS-Bioactive Bone Substitutes

Defunct

1 known investors

Find your way into BBS-Bioactive Bone Substitutes

Sign up to see every warm intro you have to BBS-Bioactive Bone Substitutes

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the BBS-Bioactive Bone Substitutes team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

BBS-Bioactive Bone Substitutes was a Finnish biomedical company that developed and sold ARTEBONE, a tricalcium-phosphate bone-graft substitute for treating bone defects.

Investors · 1

In the news

Frequently asked questions

What does BBS-Bioactive Bone Substitutes do?
BBS-Bioactive Bone Substitutes was a Finnish biomedical company that developed and sold ARTEBONE, a tricalcium-phosphate bone-graft substitute for treating bone defects.
Who are BBS-Bioactive Bone Substitutes's investors?
BBS-Bioactive Bone Substitutes's investors include Innovestor Ventures.